RE:Cannabinoid Investor Note for Feb. 1/19CWEB’s in a very very good place. Products at near compliance with Fed regulations; savvy, smart, notable management & bod; aggressive growth, impressive footprint, fiscally sound; sector recognition & normalized coverage by higher profile media outlets with CWEB oft mentioned; powerful story and brand!
$10B valuation in the next 1-2 yrs is not at all unreasonable relative to 4 of the bigs you mentioned
(considering MC, fundamentals, production assets...I personally would not group Apha in with the pigs).
At a 12usd I’m happy, proud, holding and will continue to avg in 2019 - GL comrades!